{"id":"W2092937655","doi":"10.1002/hep.20884","title":"Interferon Alfa-2b in Combination With Ribavirin for the Treatment of Chronic Hepatitis C in Children: Efficacy, Safety, and Pharmacokinetics *","year":2005,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"GlaxoSmithKline","keywords":"Ribavirin; Medicine; Pharmacokinetics; Chronic hepatitis; Hepatitis C; Interferon alfa; Pharmacology; Interferon; Internal medicine; Gastroenterology; Virology; Alpha interferon; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002078763,0.0005346824,0.001323597,0.0004187859,0.0002907382,0.0004824226,0.0003736159,0.0004256656,0.0006857674],"category_scores_gemma":[0.001593469,0.0002438963,0.0004775067,0.000575422,0.0003782774,0.0003958853,0.0002242938,0.0009028917,0.0001629979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008123774,"about_ca_system_score_gemma":0.0008698654,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001355618,"about_ca_topic_score_gemma":0.003319361,"domain_scores_codex":[0.9987233,0.0007783388,0.0001078,0.00007125161,0.0002243245,0.00009504143],"domain_scores_gemma":[0.9989523,0.0002894646,0.0004610978,0.0000369698,0.0001037964,0.0001563867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.10589,0.006202614,0.1718582,0.002635429,0.001731563,0.001437485,0.0005925813,0.002176171,0.05471902,0.0004323403,0.002474422,0.6498503],"study_design_scores_gemma":[0.04129953,0.3745762,0.4834915,0.001218957,0.003263287,0.009699293,0.0005690554,0.003395136,0.04286449,0.0003980683,0.03909693,0.000127607],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9262272,0.07018804,0.0009368671,0.0006233246,0.00007997516,0.0002796843,0.0002492612,0.00002781191,0.001387871],"genre_scores_gemma":[0.9754259,0.01871558,0.00457854,0.0002763098,0.0001753723,0.0002210051,0.0002703293,0.0000175323,0.0003194201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002078763,"threshold_uncertainty_score":0.01099366,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02058385243156201,"score_gpt":0.3278672037506863,"score_spread":0.3072833513191243,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}